Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Jul;32(3):187-95.
doi: 10.1055/s-0032-1329194. Epub 2012 Nov 1.

Chronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedside

Affiliations
Review

Chronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedside

Amanda C Peltier et al. Semin Neurol. 2012 Jul.

Abstract

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is the most common treatable chronic autoimmune neuropathy. Multiple diagnostic criteria have been established, with the primary goal of identifying neurophysiologic hallmarks of acquired demyelination. Treatment modalities have expanded to include numerous immunomodulatory therapies, although the best evidence continues to be for corticosteroids, plasma exchange, and intravenous immunoglobulin (IVIg). This review describes the pathology, epidemiology, pathogenesis, diagnosis, and treatment of CIDP.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Temporal dispersion and conduction block observed recording from the ulnar nerve at the abductor digiti minimi in a patient with CIDP. The proximal amplitude is lower with longer duration typical of temporal dispersion.

References

    1. Dyck PJ, Lais AC, Ohta M, Bastron JA, Okazaki H, Groover RV. Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc. 1975 Nov;50(11):621–637. - PubMed
    1. Burns TM. Chronic inflammatory demyelinating polyradiculoneuropathy. Arch Neurol. 2004 Jun;61(6):973–975. - PubMed
    1. AUSTIN JH. Recurrent polyneuropathies and their corticosteroid treatment; with five-year observations of a placebo-controlled case treated with corticotrophin, cortisone, and prednisone. Brain. 1958 Jun;81(2):157–192. - PubMed
    1. Katz JS, Saperstein DS, Gronseth G, Amato AA, Barohn RJ. Distal acquired demyelinating symmetric neuropathy. Neurology. 2000 Feb 8;54(3):615–620. - PubMed
    1. Lewis RA, Sumner AJ, Brown MJ, Asbury AK. Multifocal demyelinating neuropathy with persistent conduction block. Neurology. 1982 Sep;32(9):958–964. - PubMed

Publication types

MeSH terms